Chord
Provides AI platform for modern commerce operations
$7MUndisclosed
Role not disclosedM
M13
Activity from announced rounds
Activity in this selectionUndisclosed
M13 is the venture organization whose portfolio identifies Ayble Health and which OpenFX names in its Series A.
Recorded funding activity
Ayble supplies virtual digestive care. Rime develops conversational speech models, while Chord supplies commerce software. These company financings preserve distinct customer problems under the same firm identity.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $7M 1 disclosed · full round size, not this investor’s share